Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Swiss hospitals are increasingly looking to the local bond market to fund expansion -
Deutsche Bank is among the firms making a concerted effort to bulk up their capabilities in the healthcare sector, with two managing directors set to join the firm in the coming months.
-
Wells Fargo has informed staff in the US that it is delaying the reopening of its offices in the country as a result of rising Covid-19 cases.
-
MUFG is implementing a new hybrid work policy in EMEA that enshrines flexible working patterns that were introduced during the pandemic.
-
Glenmark Life Sciences, a pharmaceutical ingredients manufacturer, wrapped up a three-day bookbuild for its India IPO on Thursday. The deal, worth up to Rp15.5bn ($208.6m), was covered 15.5 times.
-
Credit spreads for corporate borrowers from sectors that will benefit the most from reopening from lockdowns are drifting wider as coronavirus infections rise thanks to the spread of the delta variant. Industries already battered by the pandemic face a rough autumn in capital markets if there is another major global wave of the virus.
